Experimental Treatment -- Oxymoron or Aspiration?
King, Nancy M.P.
Hastings Center Report. 1995 Jul-Aug; 25(4): 6-15.
Giving up the increasingly troubled distinction between "experiment" and "treatment" would make it easier to focus on informed consent and harder to beg questions about uncertainty and shared decisionmaking in medicine.
Adults; Alternatives; Biomedical Technologies; Children; Communication; Conflict of Interest; Consent; Decision Making; Disclosure; Drugs; Evaluation; Federal Government; Futility; Gene Therapy; Government; Health; Health Insurance; Health Insurance Reimbursement; Human Experimentation; Informed Consent; Insurance; Intention; Investigational Drugs; Investigational Therapies; Investigators; Malpractice; Medical Devices; Medicine; Misconduct; Nontherapeutic Research; Patient Care; Physicians; Random Selection; Regulation; Research; Risks and Benefits; Standards; Technology; Technology Assessment; Terminology; Uncertainty;
Showing items related by title, author, creator and subject.
King, Nancy M. P. (1995-07)
Schneiderman, Lawrence J.; Jecker, Nancy S. (1996)In conclusion, it is ethically imperative that physicians make clear to patients and the lay public that although medicine has important obligations, it does not have unlimited obligations, and although medicine has great ...
Schneiderman, Lawrence J.; Jecker, Nancy S. (1996-03)